Amphastar reports Q1 adjusted EPS $1.04, consensus 77c
PremiumThe FlyAmphastar reports Q1 adjusted EPS $1.04, consensus 77c
4M ago
FTC expands patent listing challenges for drugs
Premium
The Fly
FTC expands patent listing challenges for drugs
5M ago
Amphastar Pharmaceuticals (NASDAQ:AMPH) Offers Savvy Value Investors a Window of Opportunity
Premium
Market News
Amphastar Pharmaceuticals (NASDAQ:AMPH) Offers Savvy Value Investors a Window of Opportunity
5M ago
Amphastar initiated with a Neutral at BofA after 97% year-to-date rally
PremiumThe FlyAmphastar initiated with a Neutral at BofA after 97% year-to-date rally
10M ago
Amphastar initiated with a Neutral at BofA
Premium
The Fly
Amphastar initiated with a Neutral at BofA
10M ago
Amphastar Director Prins sells $263K in company shares
Premium
The Fly
Amphastar Director Prins sells $263K in company shares
10M ago
Amphastar reinstated with a Buy at Jefferies
PremiumThe FlyAmphastar reinstated with a Buy at Jefferies
1y ago
Amphastar price target raised to $66 from $55 at Piper Sandler
Premium
The Fly
Amphastar price target raised to $66 from $55 at Piper Sandler
1y ago
Amphastar management to meet with Piper Sandler
Premium
The Fly
Amphastar management to meet with Piper Sandler
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100